Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $7.0 million.

  • Icu Medical's Change in Inventory fell 4006.34% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year increase of 14114.34%. This contributed to the annual value of -$16.8 million for FY2024, which is 37683.83% down from last year.
  • Icu Medical's Change in Inventory amounted to $7.0 million in Q3 2025, which was down 4006.34% from $21.0 million recorded in Q2 2025.
  • Icu Medical's Change in Inventory's 5-year high stood at $63.9 million during Q2 2022, with a 5-year trough of -$60.6 million in Q4 2023.
  • Its 5-year average for Change in Inventory is $10.8 million, with a median of $7.0 million in 2025.
  • As far as peak fluctuations go, Icu Medical's Change in Inventory crashed by 73121.69% in 2021, and later soared by 4000875.0% in 2022.
  • Quarter analysis of 5 years shows Icu Medical's Change in Inventory stood at -$4.3 million in 2021, then skyrocketed by 1244.13% to $49.3 million in 2022, then tumbled by 223.0% to -$60.6 million in 2023, then soared by 87.76% to -$7.4 million in 2024, then surged by 194.43% to $7.0 million in 2025.
  • Its Change in Inventory was $7.0 million in Q3 2025, compared to $21.0 million in Q2 2025 and $8.2 million in Q1 2025.